A new review in Plant Cell Reports establishes protein persulfidation, a hydrogen sulfide-driven modification of cysteine residues, as a central switch that integrates plant hormone signaling,...
Human Drug Compounding Outsourcing Facility Fees
Plants have long been valued for producing some of the most powerful molecules in medicine: morphine for pain, quinine for malaria, vincristine for cancer chemotherapy, and...
Patients had adverse events after receiving a Fresenius Kabi medicine that experienced manufacturing deviations.
Bayer has looked internally for its chief medical officer, appointing Christoph Koenen to the post alongside his current clinical development role.
In this GEN webinar, Joseph Shultz (VP of technical development and manufacturing, Ottimo Pharma) and Imroz Ghangas (VP of commercial sales, Asimov) discuss strategies for achieving...
Manufacturing modern medicines is a multistage process, and each step introduces the opportunity for contamination, which can be both deadly and expensive. Recently, epinephrine injections, used...
Time has run out on BioNTech's bid to locate buyers for sites in Idar-Oberstein, Marburg and Tübingen. Including staff at a Singapore plant also slated for...
In this webinar, experts from SK pharmteco’s European and North American sites share practical experience addressing these challenges across the linker-payload development lifecycle—from facility and containment...
This list contains GDUFA facility payments received by the Agency. Data are extract from the User Fee System and GDUFA Facility User Fee Coversheets. The following...
Scan to Read